Annexon, Inc. logo ANNX - Annexon, Inc.

NEXT EARNINGS: Mar 2, 2026 (in 6 days) EPS Est: $-0.32
Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 9
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $16.00 DETAILS
HIGH: $16.00
LOW: $16.00
MEDIAN: $16.00
CONSENSUS: $16.00
UPSIDE: 222.58%
Market Cap: 593.19M
Volume: 2,674,678
Avg Volume: 2,570,158
52 Week Range: 1.285-7.18
Sector: Healthcare
Industry: Biotechnology
Beta: 1.14
Last Dividend: $N/A
Exchange: NASDAQ
Country: US
Employees: 106
IPO Date: 2020-07-24
EPS (TTM): -1.01
P/E Ratio: -5.10
Revenue (TTM): N/A
Total Assets: 350.07M
Total Debt: 28.97M
Cash & Equiv: 49.50M
Rev Growth (5Y): N/A
EPS Growth (5Y): N/A
FCF Growth (5Y): N/A
ROCE: -43.2%
Debt/Equity: 0.10

Earnings History

Date EPS Actual EPS Est EPS Surprise Rev Actual Rev Est Rev Surprise
2025-11-10 $-0.37 $-0.34 -8.8%
2025-08-14 $-0.34 $-0.36 +5.6%
2025-05-12 $-0.37 $-0.30 -23.3%
2025-03-03 $-0.33 $-0.28 -17.9%
2024-11-14 $-0.25 $-0.26 +3.8%
2024-08-12 $-0.23 $-0.23 0.0%
2024-05-13 $-0.21 $-0.32 +34.4%
2024-03-26 $-0.36 $-0.45 +20.0% $4.9M

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019 2018 2017
Revenue 0 0 0 0 0 0 0 0
Net Income (138.20M) (134.24M) (141.95M) (130.32M) (63.41M) (37.18M) (18.30M) (18.71M)
EPS -1.01 -1.77 -2.60 -3.34 -3.70 -0.97 -1.60 -0.49
Total Assets 350.07M 297.67M 285.10M 287.04M 355.95M 49.90M 48.15M 7.82M
Total Debt 28.97M 31.36M 32.86M 34.59M 0 0 107.22M 48.97M
Cash & Equivalents 49.50M 225.11M 140.02M 74.84M 268.56M 43.93M 44.17M 2.97M
Operating Cash Flow (118.01M) (121.14M) (116.31M) (106.11M) (53.09M) (28.36M) (17.19M) (19.26M)
Free Cash Flow (118.02M) (121.33M) (122.83M) (107.76M) (53.55M) (28.62M) (17.21M) (19.83M)
FCF per Share -0.86 -1.60 -2.25 -2.81 -3.16 -0.75 -1.50 -0.52
Book Value 293.11M 250.56M 231.19M 231.91M 344.28M 43.53M 37.88M (46.21M)
Cash & ST Investments 312.02M 259.72M 242.66M 242.72M 351.21M 43.93M 44.17M 2.97M
ROC Equity -0.47 -0.54 -0.61 -0.56 -0.18 -0.85 -0.48 N/A